Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 3, 2023 4:00 P.M.
Form: S-3
CIK: 0001672619
Company Name: Enliven Therapeutics, Inc.
File Number: 333-272909